Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Paper
  • Published:

Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing

Abstract

OBJECTIVE: To investigate whether weight adjusted ciprofloxacin dosing results in comparable target site concentrations in obese and lean subjects.

DESIGN: Comparative study in two populations.

SUBJECTS: Twelve obese subjects (mean weight 122±22.6 kg, 28–52 y, male : female ratio 4 : 8) and 12 age- and sex-matched lean controls (mean weight 59±8.6 kg).

METHODS: Sampling of interstitial space fluid by means of calibrated in vivo microdialysis after a weight-adjusted intravenous bolus dose of 2.85 mg/kg ciprofloxacin. Analysis of drug concentration by high pressure liquid chromatography.

RESULTS: We found significantly higher peak and trough levels of ciprofloxacin in plasma for obese subjects (9.97±5.64 and 0.44±0.10 µg/ml vs 2.59±1.06 and 0.19±0.09 µg/ml in lean subjects, P<0.05), while concentration–time curves of interstitial fluid of muscle and subcutaneous fat did not differ between the groups. Tissue penetration, expressed as AUCtissue/AUCplasma ratio was significantly lower in obese subjects (0.45±0.27 vs 0.82±0.36, P<0.01).

CONCLUSION: We conclude that the penetration process into the interstitial space fluid is impaired in obese subjects. Therefore antibiotic doses need not be adjusted for an increase in fat/water ratio. Weight-adjusted dosing based on actual body weight will yield adequate tissue levels for ciprofloxacin.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Figure 1
Figure 2

Similar content being viewed by others

References

  1. Wurtz R, Itokazu G, Rodvold K . Antimicrobial dosing in obese patients Clin Infect Dis 1997 25: 112–118.

    Article  CAS  Google Scholar 

  2. Devine BJ . Gentamicin therapy Drug Intell Clin Pharm 1974 8: 650–655.

    Article  Google Scholar 

  3. Dudley MN . Antibiotic dosing in obese children Pediatr Infect Dis J 1993 12: 420.

    Article  CAS  Google Scholar 

  4. Ungerstedt U . Microdialysis—principles and applications for studies in animal and man J Intern Med 1991 230: 365–373.

    Article  CAS  Google Scholar 

  5. Müller M, Haag O, Burgdorff T, Georgopoulos A, Weninger W, Jansen B, Stanek G, Pehamberger H, Agneter E, Eichler HG . Characterization of peripheral–compartment kinetics of antibiotics by in vivo microdialysis in humans Antimicrob Agents Chemother 1996 12: 2703–2709.

    Article  Google Scholar 

  6. Krol GJ, Beck GW, Benham T . HPLC analysis of ciprofloxacin and ciprofloxacin metabolites in body fluids J Pharm Biomed Anal 1995 14: 181–190.

    Article  CAS  Google Scholar 

  7. Wilson MG, Kelley K, Thornhill TS . Infection as a complication of total knee-replacement arthroplasty. Risk factors and treatment in sixty-seven cases J Bone Joint Surg Am 1990 72: 878–883.

    Article  CAS  Google Scholar 

  8. Medina M, Sillero M, Martinez-Gallego G, Delgado-Rodriguez M . Risk factors of surgical wound infection in patients undergoing herniorrhaphy Eur J Surg 1999 163: 191–198.

    Google Scholar 

  9. Jansson PA, Larsson A, Lönnroth PN . Relationship between blood pressure, metabolic variables and blood flow in obese subjects with or without non-insulin-dependent diabetes mellitus Eur J Clin Invest 1998 28: 813–818.

    Article  CAS  Google Scholar 

  10. Summers LK, Samra JS, Humphreys SM, Morris RJ, Frayn KN . Subcutaneous abdominal adipose tissue blood flow: variation within and between subjects and relationship to obesity Clin Sci Colch 1996 91: 679–683.

    Article  CAS  Google Scholar 

  11. Laakso M, Edelman SV, Brechtel G, Baron AD . Decreased effect of insulin to stimulate skeletal muscle blood flow in obese man. A novel mechanism for insulin resistance J Clin Invest 1990 85: 1844–1852.

    Article  CAS  Google Scholar 

  12. Traynor AM, Nafziger AN, Bertino JS Jr . Aminoglycoside dosing weight correction factors for patients of various body sizes Antimicrob Agents Chemother 1995 39: 545–548.

    Article  CAS  Google Scholar 

  13. Bauer LA, Black DJ, Lill JS . Vancomycin dosing in morbidly obese patients Eur J Clin Pharmac 1998 54: 621–625.

    Article  CAS  Google Scholar 

  14. Blouin RA, Bauer LA, Miller DD, Record KE, Griffen WO Jr . Vancomycin pharmacokinetics in normal and morbidly obese subjects Antimicrob Agents Chemother 1982 21: 575–580.

    Article  CAS  Google Scholar 

  15. Ducharme MP, Slaughter RL, Edwards DJ . Vancomycin pharmacokinetics in a patient population: effect of age, gender, and body weight Ther Drug Monit 1994 16: 513–518.

    Article  CAS  Google Scholar 

  16. Penzak SR, Gubbins PO, Rodvold KA, Hickerson SL . Therapeutic drug monitoring of vancomycin in a morbidly obese patient Ther Drug Monit 1998 20: 261–265.

    Article  CAS  Google Scholar 

  17. Allard S, Kinzig M, Boivin G, Sorgel F, LeBel M . Intravenous ciprofloxacin disposition in obesity Clin Pharmac Ther 1993 54: 368–373.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to M Müller.

Rights and permissions

Reprints and permissions

About this article

Cite this article

Hollenstein, U., Brunner, M., Schmid, R. et al. Soft tissue concentrations of ciprofloxacin in obese and lean subjects following weight-adjusted dosing. Int J Obes 25, 354–358 (2001). https://doi.org/10.1038/sj.ijo.0801555

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/sj.ijo.0801555

Keywords

This article is cited by

Search

Quick links